Scandinavian Surveillance Follow-up Programmes in Patients with Malignant Colorectal Polyps
Overview
Authors
Affiliations
Introduction: Following endoscopic removal of malignant colorectal polyps, patients may undergo completion radical resection or surveillance. The optimal surveillance strategy remains unknown. This study included colorectal departments in Scandinavian countries with a focus on follow-up periods and examination modalities for patients with endoscopically removed malignant polyps with a resection margin > 1 mm.
Methods: This study was conducted as an internet-based survey. A questionnaire was sent to all Scandinavian surgical departments performing > 20 colorectal procedures annually. Questions differed between follow-up on rectal and colonic malignant polyps with presence or absence of histological risk factors. The follow-up period was defined as short (one year), intermediate (three years) or long (five years).
Results: The majority of the departments used a long (five years) (38-59%) or intermediate (three years) (26-38%) follow-up programme. In patients with rectal malignant polyps and presence of histological risk factors, a significant difference was observed in the use of endoscopy according to length of follow-up. No difference in the use of the different modalities was seen according to length of follow-up in patients with colonic malignant polyps.
Conclusions: The follow-up on patients with endoscopically removed malignant polyps and a surveillance strategy varies both in terms of length and performed modalities. Future studies should compare long-term patient outcomes in departments employing different follow-up strategies.
Funding: none.
Trial Registration: not relevant.
Mateos Sanchez C, Quintanilla Lazaro E, Rabago L World J Gastrointest Endosc. 2024; 16(9):502-508.
PMID: 39351175 PMC: 11438583. DOI: 10.4253/wjge.v16.i9.502.
Fabian A, Bor R, Vasas B, Szucs M, Toth T, Bosze Z World J Gastrointest Endosc. 2024; 16(4):193-205.
PMID: 38680198 PMC: 11045354. DOI: 10.4253/wjge.v16.i4.193.